Zimmer Features Trabecular Metal™ Augment Shapes and Cones for Knee Revision Surgery at EFORT Congress
Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal care, is featuring a new, comprehensive range of Trabecular Metal Material augment shapes and cones for use in knee revision surgeries at the 12th annual European Federation of National Associations of Orthopaedics and Traumatology (EFORT) meeting in Copenhagen, Denmark.
During revision surgeries, surgeons are often faced with a range of small to large cavitary bone defects. The new augments are designed to fill these defects, provide a structural foundation to the existing bone and help support revision knee implants.
Trabecular Metal Tibial and Femoral Cone Augments have the potential to provide reliable structural replacement of bone and stable fixation for femoral and tibial articulating components in even challenging knee revision cases. Designed to treat deficiencies in the knee independent of the final implant position, the tapered shape of the augments fits the patient's anatomy without influencing implant alignment. The new augments are designed for use with the NexGen® Knee System.
"The launch of this fully-instrumented range of revision knee cones reinforces Zimmer's commitment to providing surgeons with the most comprehensive array of solutions to confidently approach knee revisions with the NexGen Knee System," said Jeffery A. McCaulley, President, Zimmer Reconstructive. "The broad range of anatomic sizing options now available allows surgeons to more accurately position implants and fill defects in almost all kinds of knee revision cases."
The augments are constructed from Zimmer's Trabecular Metal Material, a highly porous biomaterial that resembles the structure, function and physiology of trabecular bone. No other porous metal material is supported by the amount of peer-reviewed, published clinical data of Trabecular Metal Technology and its history of clinical success in orthopaedic applications. This novel material supports bone formation, enabling biologic fixation and a stiffness similar to cancellous bone. The elasticity of Trabecular Metal Technology provides more normal physiological loading which has the potential to decrease stress shielding and improve long-term implant fixation.
For more information, visit the Zimmer booth at EFORT or go to http://www.zimmer.com.
About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2010 sales were approximately $4.2 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.
Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.